Detalles de la búsqueda
1.
Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells.
J Neurovirol
; 22(4): 455-63, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26727904
2.
Inhibition of catechol-O-methyl transferase (COMT) by tolcapone restores reductions in microtubule-associated protein 2 (MAP2) and synaptophysin (SYP) following exposure of neuronal cells to neurotropic HIV.
J Neurovirol
; 21(5): 535-43, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26037113
3.
A new way of measuring apoptosis by absolute quantitation of inter-nucleosomally fragmented genomic DNA.
Nucleic Acids Res
; 40(15): e113, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22544708
4.
Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection.
Retrovirology
; 10: 98, 2013 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-24041034
5.
A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations.
Retrovirology
; 10: 43, 2013 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23602046
6.
Alternative coreceptor requirements for efficient CCR5- and CXCR4-mediated HIV-1 entry into macrophages.
J Virol
; 85(20): 10699-709, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21835796
7.
HIV-1 escape from the CCR5 antagonist maraviroc associated with an altered and less-efficient mechanism of gp120-CCR5 engagement that attenuates macrophage tropism.
J Virol
; 85(9): 4330-42, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21345957
8.
HIV-1 predisposed to acquiring resistance to maraviroc (MVC) and other CCR5 antagonists in vitro has an inherent, low-level ability to utilize MVC-bound CCR5 for entry.
Retrovirology
; 8: 89, 2011 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-22054077
9.
CD4 and MHC class 1 down-modulation activities of nef alleles from brain- and lymphoid tissue-derived primary HIV-1 isolates.
J Neurovirol
; 17(1): 82-91, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21165790
10.
Extremely prolonged HIV seroconversion associated with an MHC haplotype carrying disease susceptibility genes for antibody deficiency disorders.
Clin Immunol
; 137(2): 199-208, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20696618
11.
Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain.
J Virol
; 83(11): 5430-41, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19321618
12.
Measuring and monitoring apoptosis and drug toxicity in HIV patients by ligation-mediated polymerase chain reaction.
J Cell Mol Med
; 13(5): 948-58, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19120691
13.
HIV latency can be established in proliferating and nonproliferating resting CD4+ T cells in vitro: implications for latency reversal.
AIDS
; 33(2): 199-209, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30562171
14.
Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS.
Retrovirology
; 4: 89, 2007 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-18076768
15.
Analysis of Clinical HIV-1 Strains with Resistance to Maraviroc Reveals Strain-Specific Resistance Mutations, Variable Degrees of Resistance, and Minimal Cross-Resistance to Other CCR5 Antagonists.
AIDS Res Hum Retroviruses
; 33(12): 1220-1235, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28797170
16.
Quantifying susceptibility of CD4+ stem memory T-cells to infection by laboratory adapted and clinical HIV-1 strains.
Viruses
; 6(2): 709-26, 2014 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24517971
17.
HIV-1 entry and trans-infection of astrocytes involves CD81 vesicles.
PLoS One
; 9(2): e90620, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24587404
18.
Macrophage-tropic HIV-1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5.
J Leukoc Biol
; 93(1): 113-26, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23077246
19.
The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes.
PLoS One
; 8(4): e62196, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23614033
20.
The magnitude of HIV-1 resistance to the CCR5 antagonist maraviroc may impart a differential alteration in HIV-1 tropism for macrophages and T-cell subsets.
Virology
; 442(1): 51-8, 2013 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23602007